Home > About CRF > News and Events

CRF News and Events

July 28
2010

TCT for Surgeons Will Highlight Hybrid Surgical and Interventional Techniques

"Emerging Directions for the Cardiothoracic and Vascular Surgeon" to be co-sponsored by the American Association for Thoracic Surgery (AATS)

TCT for Surgeons will showcase the expansion of hybrid surgical and interventional techniques in the field that are improving outcomes for patients undergoing cardiac surgery. Now in its fourth year, the course will run during TCT 2010 from September 21-25, 2010, at the Walter E. Washington Convention Center in Washington, DC.

July 28
2010

TCT 2010 Will Significantly Impact Interventional Cardiology Practices and Patient Care

Transcatheter Cardiovascular Therapeutics (TCT) 2010, to be held September 21-25 in Washington, DC, will provide major clinical research updates for interventional cardiologists that will directly affect patient care. Leading medical researchers and clinicians from around the world will present the latest advances in techniques and training on the next generation of stents, valve repair and replacement, and the interactions and effectiveness of new medicines.

May 06
2010

New England Journal of Medicine Publishes Study That Finds Everolimus-Eluting Stent is Significantly Safer, More Effective Than Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease

Results from the SPIRIT IV clinical trial, which were first presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2009 scientific symposium, were published today in the New England Journal of Medicine.

Data from the trial, a large-scale multi-center study of nearly 4,000 patients in the U.S., showed that everolimus-eluting stents demonstrated enhanced safety and efficacy in the treatment of de novo native coronary artery lesions when compared to paclitaxel-eluting stents. The trial, which was powered for superiority for clinical endpoints without angiographic follow up, also examined the differences in performance of the two stents in patients with diabetes.

April 16
2010

ACC/i2 Summit 2010 Features Wealth of Findings on Treatments for Heart Disease

The American College of Cardiology 59th Annual Scientific Session, paired with the i2 Summit produced in partnership with CRF, was a rousing success. Held March 14-16, 2010, in Atlanta, GA, the conference featured late breaking research that marked progress on several fronts in the fight against cardiovascular disease.

Hopeful Results with Devices for Structural Disease

Mitral valve repair with the percutaneously delivered MitraClip system treats leaks just as effectively as open surgery, according to results of the EVEREST II trial. One-year clinical success rates, although statistically no worse than surgery, were somewhat lower with the device; its implantation, however, does not preclude future surgery.

April 16
2010

CTO Summit Tackles Hard-to-Treat Coronary Blockages

Just shy of 400 physicians and allied health care professionals gathered to discuss the latest trends and strategies for treating the toughest coronary blockages at the Seventh International Chronic Total Occlusion Summit, held February 4-5, 2010, in New York, NY.

Catheter-based treatments for chronic total occlusions (CTOs) are evolving, with more and more interventional cardiologists willing to attempt procedures. Despite this, undertreatment remains an issue.

More Articles...